INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 38 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $105,000 | -68.8% | 144,414 | +86.7% | 0.00% | -75.0% |
Q2 2019 | $336,000 | -17.8% | 77,348 | +38.5% | 0.01% | -33.3% |
Q1 2019 | $409,000 | -43.7% | 55,838 | -42.1% | 0.01% | -60.0% |
Q4 2018 | $727,000 | +19.4% | 96,370 | -10.6% | 0.03% | +66.7% |
Q3 2018 | $609,000 | – | 107,761 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Taylor Frigon Capital Management LLC | 414,471 | $302,000 | 0.22% |
MEITAV INVESTMENT HOUSE LTD | 2,424,516 | $1,694,000 | 0.12% |
Harel Insurance Investments & Financial Services Ltd. | 530,573 | $387,000 | 0.02% |
Virtu Financial LLC | 131,642 | $96,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 65,649 | $48,000 | 0.00% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,460,000 | $1,064,000 | 0.00% |
ARK Investment Management | 144,414 | $105,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 61,558 | $46,000 | 0.00% |
A.R.T. Advisors, LLC | 47,576 | $35,000 | 0.00% |
HRT FINANCIAL LP | 29,807 | $21,000 | 0.00% |